Johnson & Johnson pauses COVID-19 vaccine trial after unexplained illness, the second US trial now on hold

3

The Phase 3 clinical trial was temporarily halted Monday because of an unexplained illness in one of the participants, Johnson & Johnson said.

      
You Might Like